Genocea Biosciences Financials

Genocea Biosciences Stock Summary

Genocea Biosciences competes with Encore Capital, Live Ventures, United Homes, MI Homes, and Arrow Financial. Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Genocea Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 74 people.

Genocea Biosciences Key Financial Ratios

Genocea Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Genocea Biosciences's current stock value. Our valuation model uses many indicators to compare Genocea Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genocea Biosciences competition to find correlations between indicators driving Genocea Biosciences's intrinsic value. More Info.Genocea Biosciences is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genocea Biosciences' earnings, one of the primary drivers of an investment's value.

Genocea Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Genocea Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genocea Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genocea Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Genocea Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genocea Biosciences's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

If you are still planning to invest in Genocea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genocea Biosciences' history and understand the potential risks before investing.